4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012221
Director acquired 747 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Young Caroline Director | 2023-08-16 | Other acquisition 10b5-1 | +65 | $1.64 | $107 | 20,652 | D: show line 1 in the form |
| Young Caroline Director | 2023-08-17 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 20,717 | D: show line 2 in the form |
| Young Caroline Director | 2023-08-18 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 20,782 | D: show line 3 in the form |
| Young Caroline Director | 2023-08-21 | Other acquisition 10b5-1 | +65 | $1.68 | $109 | 20,847 | D: show line 4 in the form |
| Young Caroline Director | 2023-08-22 | Other acquisition 10b5-1 | +65 | $1.72 | $112 | 20,912 | D: show line 5 in the form |
| Young Caroline Director | 2023-08-23 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 20,977 | D: show line 6 in the form |
| Young Caroline Director | 2023-08-24 | Other acquisition 10b5-1 | +27 | $1.69 | $46 | 21,004 | D: show line 7 in the form |
| Young Caroline Director | 2023-08-25 | Other acquisition 10b5-1 | +65 | $1.70 | $111 | 21,069 | D: show line 8 in the form |
Loading xslF345X05/marketforms-62532.xml…